Can Men Develop Lupus? Understanding Gender Differences in Systemic Lupus Erythematosus

Yes—Men Can and Do Develop Lupus

While systemic lupus erythematosus (SLE) is often perceived as a "woman's disease," men absolutely can—and do—develop this complex, chronic autoimmune condition. In fact, approximately 1 in 10 people diagnosed with SLE is male. Though the disease disproportionately affects women—especially during childbearing years—the reality is that lupus does not discriminate by gender. Male patients face unique biological, diagnostic, and therapeutic challenges that warrant greater clinical attention and public awareness.

What Drives Lupus in Men? Beyond Hormones Alone

Lupus arises from a confluence of genetic susceptibility, environmental triggers, and immune dysregulation—not just hormonal fluctuations. While estrogen has long been linked to increased autoimmune activity, recent research confirms that male lupus patients often exhibit altered sex hormone ratios, including relatively higher estradiol-to-testosterone levels compared to healthy males. Yet hormones are only part of the story: epigenetic factors, X-chromosome–linked immune genes (even in XY individuals), and variations in toll-like receptor signaling all contribute to aberrant B- and T-cell responses. Importantly, men may carry distinct genetic risk variants—such as certain HLA-DR and IRF5 polymorphisms—that influence disease onset, severity, and organ involvement.

Clinical Differences: Why Male Lupus Often Presents More Aggressively

Studies consistently show that men with SLE tend to experience more severe disease manifestations at diagnosis and over time. Compared to women, they are significantly more likely to develop:

• Renal involvement (lupus nephritis)—often with earlier onset and faster progression to proliferative or crescentic forms;
• Cardiovascular complications, including accelerated atherosclerosis and myocarditis;
• Hematologic abnormalities, such as severe thrombocytopenia or hemolytic anemia;
• Neuropsychiatric lupus, including seizures and cognitive dysfunction.

This heightened multi-organ burden means men are more frequently hospitalized, require higher cumulative immunosuppressive doses, and face elevated risks of irreversible organ damage.

Treatment Challenges and Safety Considerations for Men

Male patients often respond less robustly to standard therapies—including hydroxychloroquine and mycophenolate—and may require earlier escalation to biologics like belimumab or rituximab. Crucially, they also face disproportionate treatment-related risks. Long-term glucocorticoid use, for example, correlates strongly with osteonecrosis—particularly avascular necrosis of the femoral head—a complication reported at nearly twice the rate in men versus women with SLE. Additionally, testosterone suppression from chronic inflammation and immunosuppressants can exacerbate fatigue, muscle loss, and metabolic syndrome—factors rarely addressed in routine lupus management protocols.

A Call for Precision Care and Greater Awareness

Despite their smaller numbers, men with lupus represent a high-risk, underserved population. Delayed diagnosis—often due to low clinical suspicion—is common, leading to preventable morbidity. Moving forward, rheumatologists, primary care providers, and patient advocacy groups must prioritize gender-informed screening tools, tailored treatment algorithms, and inclusive clinical trial enrollment. For patients and families: early recognition of symptoms like persistent fatigue, unexplained fevers, joint swelling, foamy urine, or skin rashes—even without classic "butterfly" facial lesions—is critical. Because in lupus, timely intervention doesn't just improve outcomes—it saves lives.